The AMR Narrative

Why Responsible Antibiotic Use in Pets Matters to Everyone

Antibiotics are one of the most important tools in modern medicine. They save lives every day treating infections in both people and animals that would once have been fatal. But their effectiveness is under threat due to a growing global problem called antimicrobial resistance (AMR).

AMR occurs when infection causing microbes (germs) adapt and become resistant to the antimicrobial medicines designed to treat them, antibiotics being one of those medicines alongside antifungals, antivirals and antiparasitics. This means infections can become more difficult to treat or even impossible to treat. While this might sound like something that only affects hospitals, it’s something that involves all of us including our pets.

Like many global challenges, AMR can feel overwhelming. But small, everyday decisions can make a real difference. One of the most important is making sure antibiotics are only used when they are truly needed.

A Common Situation

Imagine this: your dog has been unwell for several days off food, low in energy, and now with severe diarrhoea. Naturally, you are worried and take them to the vet.

Your vet recommends hospital care, fluids, and close monitoring. At this point, you might expect antibiotics to be given straight away after all, your pet is clearly very sick.

But sometimes, the best decision is not to use antibiotics.

Why Antibiotics Aren’t Always the Answer

Your vet carefully assesses whether antibiotics are needed. In this case, although your dog is clearly unwell, there are no signs of a bacterial infection or more serious complications. This means antibiotics are unlikely to help at this stage.

Instead, your pet can be closely monitored and supported with treatments like fluid therapy, while the veterinary team keeps a close eye for any changes that might mean antibiotics are needed later.

Research has shown that in some conditions like this, antibiotics do not improve recovery. In fact, using them when they aren’t needed can do more harm than good, disrupt your pet’s natural balance of bacteria and contributing to the growing problem of antibiotic resistance. Research over the past decade has made it clear that antibiotics can significantly affect the gut microbiome (the community of beneficial bacteria living in the digestive system), especially when used unnecessarily.

Why Not Use Antibiotics “Just in Case”?

It’s completely natural to want to do everything possible for your pet. However, giving antibiotics “just in case” isn’t always the safest option.

Unnecessary antibiotic use can:

  • Encourage resistant bacteria to develop
  • Disrupt your pet’s normal, healthy bacteria
  • Make future infections harder to treat
  • Impact both animal and human health

This is why vets make careful, evidence-based decisions about when antibiotics are truly needed.

The Bigger Picture: Shared Health

The health of animals, people, and the environment are closely connected. Resistant bacteria can spread between pets and humans, and even through the wider environment.

This means that how antibiotics are used in pets doesn’t just affect individual animals it’s part of a global effort to protect these vital medicines for everyone.

Why This Matters for your Health

Antibiotic resistance is already affecting some of the most advanced areas of human medicine.

For example, many cancer patients rely on chemotherapy to treat their disease. While chemotherapy targets cancer cells, it can also weaken the body and disrupt the natural balance of bacteria in the gut. This makes patients more vulnerable to infections.

Antibiotics are often needed to protect these patients. But there’s a growing problem: the more antibiotics are used, especially over longer periods, the more opportunity bacteria have to adapt and become resistant.

At the same time, chemotherapy itself can disturb the body’s normal bacteria, allowing more harmful bacteria to take over. This combination disrupted natural defences and increased antibiotic use creates the perfect conditions for resistant bacteria to develop and spread.

In some cases, this means infections become much harder to treat. Treatments may be less effective, recovery can be slower, and the risks to the patient increase.

Researchers are now exploring ways to restore healthy gut bacteria through approaches like probiotics and other therapies to improve outcomes. But protecting antibiotics in the first place remains essential.

When Antibiotics Stop Working

It’s easy to think of antibiotic resistance as something distant but it has very real consequences.

Imagine going into hospital for a routine operation, like a hip replacement. The surgery goes well, but afterwards an infection develops. Normally, this would be treatable. But the bacteria are resistant to multiple antibiotics, and what should have been a straightforward recovery becomes life-threatening.

Or imagine recovering from serious illness, only to develop an infection that doctors struggle to treat because the usual antibiotics no longer work.

These situations are already happening. Antibiotic resistance is making infections harder to treat, leading to longer hospital stays and, in some cases, loss of life.

What You Can Do as a Pet Owner

You play an important role in this effort. Here’s how you can help:

  • Trust your vet’s advice if antibiotics aren’t prescribed
  • Avoid asking for antibiotics as a quick fix
  • Follow instructions carefully when antibiotics are prescribed
  • Never use leftover or shared medications
  • Return for check-ups if your pet isn’t improving

Good communication with your vet is key, they are always happy to explain their decisions and what to look out for at home.

Don’t Be Afraid to Ask Questions

If your pet is prescribed antibiotics, it’s always okay to ask why. Understanding the reason behind a treatment helps you feel confident in your pet’s care and ensures antibiotics are being used appropriately.

You might consider asking:

  • What infection are we treating?
  • Are antibiotics definitely needed in this case?
  • Are there any alternatives or supportive treatments?
  • What signs should I watch for if my pet doesn’t improve?

These aren’t challenging questions, they form a part of good communication. Your vet wants to work with you to make the best decisions for your pet.

A Shared Responsibility

Every time antibiotics are used, it has an impact. By using them responsibly in our pets, we help protect these medicines for ourselves, our families, and future generations.

When your vet decides not to prescribe antibiotics, it’s not because they are withholding treatment it’s because they are making a careful, informed decision to protect your pet and contribute to a much bigger effort.

Because one day, any of us or someone we love may rely on antibiotics to survive.

And we need them to work.

Cameron Prior

BVSc MSc PgCert CertAVP DipECVIM-CA MRCVS

Cameron is a European Diplomate in Small Animal Internal Medicine. Passionate about fungal disease, antimicrobial stewardship, endocrinopathy, and facilitating multiple studies to enhance the evidence base of veterinary medicine. Keen to build collaborative projects with colleagues across Europe and to promote clinical research in practice.

Disclaimer: The information provided on this website is intended for educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Reliance on any information provided on this website is solely at your own risk. The website owners and authors are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. It is recommended that you consult a qualified healthcare professional for individualised medical and health-related guidance.

Cameron Prior

Cameron Prior

BVSc MSc PgCert CertAVP DipECVIM-CA MRCVS

RCVS Recognised Specialist in Small Animal Medicine

Cameron is a European Diplomate in Small Animal Internal Medicine. Passionate about fungal disease, antimicrobial stewardship, endocrinopathy, and facilitating multiple studies to enhance the evidence base of veterinary medicine. Keen to build collaborative projects with colleagues across Europe and to promote clinical research in practice.

Abi Mc Alester

Abi Mc Alester

I am a graduate from the National University of Galway with an Honours BSc in Pharmacology, and a recent graduate from Maynooth University with a MSc in Immunology & Global Health. Throughout university, I was an active member of the Global Health Network, which was a student-led group focusing on health, equity, and international development. Here is where I became interested in the global impact of AMR and the multiple factors that influence its spread. I chose to focus my studies on the mechanisms behind resistance and vaccination design; however, I understand that in order to have a global impact, there needs to be global awareness.

The AMR Narrative provides lived experiences and stories from those affected by resistance, something I believe is so important and why I wanted to help share these stories on social media. Translating scientific knowledge into digestible and understandable language is critical for fighting resistance.

Nduta Kamere

Nduta is a global health pharmacist and AMR consultant recognised for her leadership in antimicrobial stewardship, One Health, and healthcare equity. She has shaped AMR strategies and advanced healthcare accessibility across Africa, with a significant portfolio that includes contributions to the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programmes. As Technical Lead, she oversaw the co-development of the Quadripartite Antimicrobial Resistance Toolkit for Youth Engagement, now used globally to drive advocacy and behaviour change.

Her expertise spans supply chains, pricing, and substandard and falsified medicines, and her research is published in the WHO Bulletin and peer-reviewed journals, informing regional and global AMR policy and practice.

Dr Marie-Anne Bouldouyre

Dr Marie-Anne Bouldouyre is an infectious diseases physician and hospital practitioner in Paris. Twelve years of clinical work in a suburban hospital shaped her understanding of access to care, patient relationships, and the daily reality of antimicrobial resistance.

Since 2022, she has led the Regional Antibiotic Stewardship Centre in Île-de-France and coordinates the national network, working with a multidisciplinary team to promote responsible antibiotic use and strengthen collaboration among healthcare professionals. She also continues to manage complex infections at Saint-Louis Hospital.

Convinced that antimicrobial resistance cannot be tackled by healthcare workers alone, she advocates for the active involvement of patients : understanding, questioning, and taking part in decisions about antibiotics. Their stories are essential to making this issue visible and concrete.

She is proud to collaborate with initiatives such as The AMR Narrative and hopes to foster similar projects in France to give patients a voice in this shared fight.

Dr Erva Cinar

Dr Erva Cinar is a London based paediatric resident doctor and clinical researcher with interest in infectious diseases.

She is currently completing a Master’s in Public Health at the London School of Hygiene & Tropical Medicine. Through the World Medical Association’s Junior Doctor’s Network (WMA-JDN) AMR Working Group, she engages in policy and advocacy on antimicrobial resistance and stewardship at global level.

Alongside her clinical and academic roles, she works with the Royal College of Paediatrics and Child Health (RCPCH) and the International Child Health Group (ICHG); leads on organising teaching resources and educational events to improve research skills for UK paediatric trainees and for global child health professionals.

Hamu Madzedze

Hamu Madzedze is a seasoned Zimbabwean journalist with over 15 years’ experience.

She previously worked for the Zimbabwe Broadcasting Corporation as a reporter and sub-editor, before establishing an independent website, 365HealthDiaries, which focuses on health and gender issues.

She holds a BA in Media Studies and a BA (Special Honours) in Communication and Media from the Zimbabwe Open University, as well as a diploma from the Christian College of Southern Africa.

Her work has been recognised with several awards, including the Global AMR Special Mention Award (2024), the Sexual Health Rights and Equity Fellowship Special Mention Award (2025), and the Merck Foundation Award (2024) for outstanding coverage of health issues, gender, infertility, and genital mutilation, where she achieved third position in the Online Category.

Hamu is passionate about addressing AMR through the media.

Jomana F. Musmar

Dr. Jomana Musmar is a distinguished global policy expert and proactive leader with over fifteen years of government experience in strategic planning, operational design, and policy execution. Renowned for simplifying complex topics with expertise and diplomacy, she has spearheaded innovative solutions to global health challenges, shaped impactful policies, and advanced national and international missions.

As the Executive Director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, she established and led the council’s operations, liaising with over 600 experts, worldwide, across government, industry, and academia. Her efforts culminated in the development of critical recommendations addressing antimicrobial resistance and interrelated One Health issues, influencing both domestic and global health strategies.

In her tenure as Deputy Director of Strategic Initiatives for the Office of Infectious Diseases and HIV/AIDS Policy, at the US Department of Health and Human Services, Dr. Musmar oversaw the formulation and implementation of national health strategies for vaccines and a range of infectious diseases including HIV/AIDS and viral hepatitis. Her leadership and technical expertise facilitated groundbreaking policies during national emergencies, including responses to the COVID-19 pandemic, and initiatives to combat congenital syphilis and childhood vaccination disruptions. Dr. Musmar holds a Ph.D. in Biodefense from George Mason University, a Master’s degree in Biomedical Science policy and Advocacy from Georgetown University, and is a Lean Six Sigma Black Belt. Fluent in English and Arabic, she is a sought-after speaker and advisor, having represented the United States at premier global health conferences.

Her published works on antimicrobial resistance, pandemic preparedness, and national health security underscore her reputation as a thought leader and innovator in public health and biodefense.

Chris Shaffer

Chris Shaffer was a music, special education teacher, and high school principal for 45 years. At the end of his educational career, he was thrust into the world of AMR infections when a number of abdominal surgeries left him with an E-coli infection which failed to respond to antibiotics. After doctors in the USA left him with little hope for a cure, diminishing health, and a bleak prognosis, he set out on his own.

Chris found success in phage therapy at the Eliava Phage Therapy Center in Tbilisi, Georgia. With phage therapy giving Chris his life back, he has dedicated his retirement years to advocating for and helping raise awareness of phage therapy used for AMR infections. He tells the story of his phage journey in a book titled, Finding Phage: How I Partnered with a Friendly Virus to Cure My Deadly Bacterial Superinfection. His website, phagetherpyusa.com helps others learn to understand the healing power of phage therapy.

Demi Christofi

Demi is an Associate Scientific Director at a medical communications agency, with a background in microbiology and a longstanding focus on antimicrobial resistance. She holds an MSc in Microbiology, where she first became interested in the global challenge of resistance and the need to bring scientific understanding to wider audiences.

Demi’s career has centred on a simple but powerful belief: that how we communicate science matters. Her work focuses on making complex data clear, engaging, and accessible – whether for healthcare professionals, policy makers, or the patients most affected by infection and resistance. She has contributed to a wide range of AMR-focused projects, including educational programmes, congress communications and stewardship initiatives.

A central thread in Demi’s work is the importance of the patient voice. She is passionate about making sure real-world experiences of treatment failure, recurrent infections, and the anxiety surrounding resistance are not lost in the data. She believes that listening to patients and involving them meaningfully is essential for shaping more effective, human-centred responses to AMR.

Demi is also a strong advocate of the One Health approach, recognising AMR as a complex, interconnected issue that spans human health, animal health, and the environment. She is particularly drawn to efforts that move beyond siloed thinking and focus on practical, joined-up solutions.

In 2025, Demi joined The AMR Narrative as an Independent Advisor, where she supports the charity’s mission to centre communication, community, and inclusion in the global AMR response.

Outside of work, she is a Girlguiding unit leader and a qualified yoga teacher. These roles reflect her commitment to care, learning, and creating supportive spaces for others.

Andrea Hartley

Andrea has worked in health communications and campaigning for 3 decades. She is committed to fighting AMR through timely and appropriate communications globally,.

Andrea set up Skating Panda, the creative social and environmental impact consultancy, over a decade ago and drives its impact and growth. Focused on original and lasting public interest communications as well as issue strategy and advocacy, the Panda team has a track record of prompting tipping points in the status quo that drive better social and planetary outcomes.

Andrea’s combination of commercial marketing and development experience with deep issue knowledge have been sought by decision-makers at global summits, corporate and NGO board members, and have enabled her to set up multi-million fundraising platforms and push through policies that change and save lives. 

Andrea is Vice Chair of mothers2mothers, the world’s largest employer of women living with HIV, and a Board Director of Maymessy, a food poverty social enterprise.

A lifelong advocate for gender equality, she played a key role in establishing the UK’s Women’s Equality Party.

Esmita Charani

Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.

She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.